Bio-Rad Laboratories this week launched the Profinity eXact Fusion-tag System for the purification of affinity-tagged proteins.
 
The system uses an immobilized, engineered subtilisin protease to perform affinity binding and tag cleavage, significantly shortening the purification process, the company said in a statement. Profinity eXact allows researchers to purify tag-free proteins in one hour, Tanis Correa, senior product managmer for Bio-Rad Lab Chromatography products, said in the statement.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

NPR reports that with medical data being big business, some companies want to get patients involved.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.